Precise Nanodrug Delivery Systems with Cell-specific Targeting for ALI/ARDS Treatment.

[1]  Jin Gao,et al.  Remote Co-loading of amphipathic acid drugs in neutrophil nanovesicles infilled with cholesterol mitigates lung bacterial infection and inflammation , 2023, Biomaterials.

[2]  Jia-feng Wang,et al.  Corrigendum: PD-L1 maintains neutrophil extracellular traps release by inhibiting neutrophil autophagy in endotoxin-induced lung injury , 2022, Frontiers in Immunology.

[3]  Yiyun Cheng,et al.  Fluorous-Tagged Peptide Nanoparticles Ameliorate Acute Lung Injury via Lysosomal Stabilization and Inflammation Inhibition in Pulmonary Macrophages. , 2022, Small.

[4]  Changju Chun,et al.  Neutrophil membrane-coated therapeutic liposomes for targeted treatment in acute lung injury , 2022, International journal of pharmaceutics.

[5]  Hong Wang,et al.  Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[6]  S. Turvey,et al.  Nano‐Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury , 2021, Advanced science.

[7]  C. Fan,et al.  Macrophage Polarization Modulated by NF-κB in Polylactide Membranes-Treated Peritendinous Adhesion. , 2021, Small.

[8]  Samuel M. Brown,et al.  Characteristics and Outcomes of US Patients Hospitalized With COVID-19. , 2021, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[9]  V. Rotello,et al.  Supramolecular Arrangement of Protein in Nanoparticle Structures Predicts Nanoparticle Tropism for Neutrophils in Acute Lung Inflammation , 2021, Nature Nanotechnology.

[10]  Wei He,et al.  Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome , 2021, Acta Pharmaceutica Sinica B.

[11]  Conglian Yang,et al.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design , 2021, Acta Pharmaceutica Sinica B.

[12]  Qun Chen,et al.  Epithelium- and endothelium-derived exosomes regulate the alveolar macrophages by targeting RGS1 mediated calcium signaling-dependent immune response , 2021, Cell Death & Differentiation.

[13]  D. Scherman,et al.  PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System , 2021, Nanomaterials.

[14]  Yucai Wang,et al.  Voluntary‐Opsonization‐Enabled Precision Nanomedicines for Inflammation Treatment , 2020, Advanced materials.

[15]  Kyung Soo Hong,et al.  Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm , 2020, Biomaterials.

[16]  Wonhwa Lee,et al.  Bioinspired DNase‐I‐Coated Melanin‐Like Nanospheres for Modulation of Infection‐Associated NETosis Dysregulation , 2020, Advanced science.

[17]  Yunbing Wang,et al.  Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation. , 2020, ACS nano.

[18]  Xiao-Neng Mo,et al.  Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study , 2020, American journal of respiratory and critical care medicine.

[19]  Huang-Ping Yu,et al.  Suppression of neutrophilic inflammation can be modulated by the droplet size of anti-inflammatory nanoemulsions. , 2020, Nanomedicine.

[20]  Yongmei Cao,et al.  Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury , 2020, Cell Death & Differentiation.

[21]  Hong Yang,et al.  Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury , 2020, Journal of Nanobiotechnology.

[22]  Weilin Wang,et al.  Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[23]  J. Nemzek,et al.  Inhibition of neutrophil elastase prevents neutrophil extracellular trap formation and rescues mice from endotoxic shock. , 2020, Biomaterials.

[24]  C. Villa,et al.  Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier , 2020, Proceedings of the National Academy of Sciences.

[25]  A. Mócsai,et al.  Neutrophils as emerging therapeutic targets , 2020, Nature Reviews Drug Discovery.

[26]  J. Beitler.  Lung protection in acute respiratory distress syndrome: what should we target? , 2019, Current opinion in critical care.

[27]  S. Mitragotri,et al.  Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases. , 2019, Advanced drug delivery reviews.

[28]  C. Zhang,et al.  Nanoparticle-induced neutrophil apoptosis increases survival in sepsis and alleviates neurological damage in stroke , 2019, Science Advances.

[29]  G. Derumeaux,et al.  CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension , 2019, European Respiratory Journal.

[30]  Qian Li,et al.  NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization. , 2019, Experimental cell research.

[31]  G. Wei,et al.  Recent progress in drug delivery , 2019, Acta pharmaceutica Sinica. B.

[32]  Bowen Yang,et al.  E-Selectin-Binding Peptide–Modified Bovine Serum Albumin Nanoparticles for the Treatment of Acute Lung Injury , 2019, AAPS PharmSciTech.

[33]  C. Zhang,et al.  pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury. , 2019, ACS applied materials & interfaces.

[34]  Yongzhong Du,et al.  Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy , 2018, Journal of Nanobiotechnology.

[35]  Vladimir R Muzykantov,et al.  Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae. , 2018, Biomaterials.

[36]  Hamideh Parhiz,et al.  PECAM‐1 directed re‐targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E‐mediated uptake , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Yongzhong Du,et al.  Sialic Acid-Functionalized PEG-PLGA Microspheres Loading Mitochondrial-Targeting-Modified Curcumin for Acute Lung Injury Therapy. , 2018, Molecular pharmaceutics.

[38]  E. Nozik-Grayck,et al.  Targeted delivery of YSA-functionalized and non-functionalized polymeric nanoparticles to injured pulmonary vasculature , 2018, Artificial cells, nanomedicine, and biotechnology.

[39]  C. Villa,et al.  Vascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than Antibodies. , 2018, Bioconjugate chemistry.

[40]  P. Baatsen,et al.  Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy. , 2018, Acta biomaterialia.

[41]  Martha E. Grady,et al.  Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles , 2018, Advanced materials.

[42]  Xiaofang Huang,et al.  The Role of Macrophages in the Pathogenesis of ALI/ARDS , 2018, Mediators of inflammation.

[43]  J. Bena,et al.  Psychometric Testing of the Personal Workplace Safety Instrument for Emergency Nurses , 2018, Worldviews on evidence-based nursing.

[44]  L. Thoma,et al.  Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury , 2018, Pharmaceutical Research.

[45]  C. Villa,et al.  Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1) , 2018, Scientific Reports.

[46]  M. Hoenerhoff,et al.  Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation. , 2017, ACS nano.

[47]  K. G. Rajeev,et al.  Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates , 2017, Nucleic acids research.

[48]  J. Brenner.  Nanomedicine for the Treatment of Acute Respiratory Distress Syndrome. The 2016 ATS Bear Cage Award-winning Proposal. , 2017, Annals of the American Thoracic Society.

[49]  Arthur Slutsky,et al.  Mechanical Ventilation to Minimize Progression of Lung Injury in Acute Respiratory Failure. , 2017, American journal of respiratory and critical care medicine.

[50]  C. Villa,et al.  Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1 , 2017, PloS one.

[51]  Yongjun Wei,et al.  Celastrol attenuates impairments associated with lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) in rats , 2017, Journal of immunotoxicology.

[52]  Yuan Zhang,et al.  Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury , 2017, Drug delivery.

[53]  Yongzhong Du,et al.  Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy , 2017, Drug delivery.

[54]  Guosong Chen,et al.  Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response , 2016, ACS macro letters.

[55]  Z. Sideratou,et al.  Triphenylphosphonium Decorated Liposomes and Dendritic Polymers: Prospective Second Generation Drug Delivery Systems for Targeting Mitochondria. , 2016, Molecular pharmaceutics.

[56]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[57]  Jin Gao,et al.  Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection. , 2015, ACS nano.

[58]  C. Sung,et al.  Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[59]  J. F. Burrows,et al.  Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation , 2015, Science Translational Medicine.

[60]  V. Muzykantov,et al.  Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Hong Yang,et al.  Amino Acid-Dependent Attenuation of Toll-like Receptor Signaling by Peptide-Gold Nanoparticle Hybrids. , 2015, ACS nano.

[62]  C. Esmon,et al.  Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  L. J. Lee,et al.  Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexes. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[64]  R. Sadikot.  The potential role of nano- and micro-technology in the management of critical illnesses. , 2014, Advanced drug delivery reviews.

[65]  M. Matthay,et al.  Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[66]  C. Lehr,et al.  Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics , 2014 .

[67]  V. Muzykantov,et al.  ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation , 2014, PloS one.

[68]  Robert J Levy,et al.  Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation. , 2014, Biomaterials.

[69]  V. Muzykantov,et al.  Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Jaehyung Cho,et al.  Prevention of Vascular Inflammation by Nanoparticle Targeting of Adherent Neutrophils , 2014, Nature nanotechnology.

[71]  C. Esmon,et al.  Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor , 2013, PloS one.

[72]  C. Esmon,et al.  Platelet Endothelial Cell Adhesion Molecule Targeted Oxidant-Resistant Mutant Thrombomodulin Fusion Protein with Enhanced Potency In Vitro and In Vivo , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[73]  D. Atochin,et al.  Anti-Inflammatory Effect of Targeted Delivery of SOD to Endothelium: Mechanism, Synergism with NO Donors and Protective Effects In Vitro and In Vivo , 2013, PloS one.

[74]  Yuan Zhang,et al.  Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats , 2013, PloS one.

[75]  M. Matthay,et al.  Regulation and repair of the alveolar-capillary barrier in acute lung injury. , 2013, Annual review of physiology.

[76]  V. Muzykantov,et al.  Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. , 2012, ACS nano.

[77]  Silvia Muro,et al.  Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[78]  V. Muzykantov,et al.  Targeted Endothelial Delivery of Nanosized Catalase Immunoconjugates Protects Lung Grafts Donated After Cardiac Death , 2011, Transplantation.

[79]  V. Muzykantov,et al.  Catalase and Superoxide Dismutase Conjugated with Platelet-Endothelial Cell Adhesion Molecule Antibody Distinctly Alleviate Abnormal Endothelial Permeability Caused by Exogenous Reactive Oxygen Species and Vascular Endothelial Growth Factor , 2011, Journal of Pharmacology and Experimental Therapeutics.

[80]  Mingyao Liu,et al.  The potential of nanoscale combinations of self-assembling peptides and amino acids of the Src tyrosine kinase inhibitor in acute lung injury therapy. , 2011, Biomaterials.

[81]  V. Muzykantov,et al.  PECAM‐targeted delivery of SOD inhibits endothelial inflammatory response , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  N. McElvaney,et al.  A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation , 2010, AAPS PharmSciTech.

[83]  D. Harrison,et al.  Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium , 2009, Journal of Pharmacology and Experimental Therapeutics.

[84]  E. Abraham,et al.  Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[85]  S. Kawakami,et al.  Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model , 2008, Molecular Pharmacology.

[86]  V. Muzykantov,et al.  Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[87]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[88]  D. Sheppard,et al.  Integrin αvβ5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function , 2007 .

[89]  Y. Lau,et al.  Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.

[90]  Michel Theron,et al.  A probable role for IFN-γ in the development of a lung immunopathology in SARS , 2005, Cytokine.

[91]  V. Muzykantov,et al.  Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. , 2005, Current pharmaceutical design.

[92]  Jun Xu,et al.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.

[93]  V. Muzykantov,et al.  ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. , 2005, Blood.

[94]  G. Bernard,et al.  Neutrophil elastase inhibition in acute lung injury: Results of the STRIVE study , 2004, Critical care medicine.

[95]  J. Sung,et al.  Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome , 2004, Clinical and experimental immunology.

[96]  V. Muzykantov,et al.  Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. , 2003, American journal of physiology. Cell physiology.

[97]  V. Muzykantov,et al.  ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. , 2003, Blood.

[98]  V. Muzykantov,et al.  PECAM-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide. , 2003, Free radical biology & medicine.

[99]  V. Muzykantov,et al.  A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 , 2003, Journal of Cell Science.

[100]  B. Yoder,et al.  Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. , 2001, American journal of respiratory and critical care medicine.

[101]  Simon C Watkins,et al.  Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.

[102]  A. Al-Mehdi,et al.  Normoxic lung ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. , 1997, American journal of respiratory and critical care medicine.

[103]  Jen-kun Lin,et al.  Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.

[104]  V. Muzykantov,et al.  Immunotargeting of antioxidant enzyme to the pulmonary endothelium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[105]  V. Torchilin,et al.  Characterization of in vivo immunoliposome targeting to pulmonary endothelium. , 1990, Journal of pharmaceutical sciences.

[106]  S. Chida,et al.  ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASE , 1980, The Lancet.

[107]  Katharina Gaus,et al.  Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. , 2017, Nature nanotechnology.

[108]  L. Thoma,et al.  Non-Invasive Detection of Lung Inflammation by Near-Infrared Fluorescence Imaging Using Bimodal Liposomes , 2015, Journal of Fluorescence.

[109]  A. Randolph,et al.  The acute respiratory distress syndrome. , 1996, New England Journal of Medicine.